IMC Chicago’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Buy
71,000
+4,100
+6% +$18.1K ﹤0.01% 5252
2026
Q1
$242K Buy
+66,900
New +$231K ﹤0.01% 4820
2025
Q4
– Sell
-32,600
Closed -$221K – 4265
2025
Q3
$221K Sell
32,600
-53,700
-62% -$444K ﹤0.01% 3525
2025
Q2
$1.18M Sell
86,300
-32,700
-27% -$309K ﹤0.01% 2373
2025
Q1
$647K Buy
+119,000
New +$675K ﹤0.01% 2516
2024
Q3
– Sell
-32,800
Closed -$225K – 2926
2024
Q2
$225K Buy
+32,800
New +$300K ﹤0.01% 2561

Other funds holding LFMD

IMC Chicago's LFMD Position: Q2 2026 in Review

IMC Chicago increased its LifeMD (LFMD) stake by 36% in Q2 2026, buying an estimated $95K and bringing the position to 82,076 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #5082.

IMC Chicago first reported a position in LFMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $867K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • IMC Chicago held 82,076 shares of LifeMD worth $339K as of Q2 2026.
  • IMC Chicago bought 21,522 LifeMD shares in Q2 2026, an estimated $95K.
  • LifeMD made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5082 holding.
  • IMC Chicago first reported a position in LifeMD in Q1 2025 and has held it in 5 quarters since.
  • IMC Chicago's LifeMD position peaked at $867K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.